Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cellulose-derived viscosity modifier (substance) |
Is a |
True |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
agent viscoélastique ophtalmique |
Is a |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbomer (substance) |
Is a |
True |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Viscosity modifier adverse reaction (disorder) |
Causative agent (attribute) |
True |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
allergie au modificateur de viscosité |
Causative agent (attribute) |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing polyvinyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polyvinyl alcohol 1.4% single-use eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely polyvinyl alcohol 14 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polyvinyl alcohol 1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Povidone 5% single-use eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Viscosity modifier |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Discharge solidifying sachets and granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing povidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Discharge solidifying agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Discharge solidifying tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naphazoline hydrochloride + polyvinyl alcohol + zinc sulphate 0.02%wv/0.25%wv/0.25%wv drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Discharge solidifying strip |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Xanthan gum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing Acacia (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acacia- and starch- and tragacanth-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
allergie au modificateur de viscosité |
Causative agent (attribute) |
False |
Viscosity modifier |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |